findmyKOL
Clinical trialNCT04305743RecruitingPhase 4Interventional

Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A

SponsorUniversity of South FloridaEnrollment60Incontinence, UrgeIncontinence, UrinaryNocturiaUrinary Bladder, OveractiveUrinary Frequency More Than Once at NightUrinary Urge Incontinence
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Currently, in clinical practice there has been no standardization in the number of injections a single dose of intradetrusor onabotulinumtoxin A is administered in. Given the increasing use of this treatment modality, the aim of this study is to compare outcomes for patients given a 100 unit dose of onabotulinumtoxin A split into 5 as compared to 20 injections for the treatment of overactive bladder or urgency urinary incontinence refractory to medical treatment.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Medstar Washington Hospital Center

    Washington D.C., District of Columbia, United States

    Amy Park, MDCheryl Iglesia, MDNancy Ringel, MD
    Recruiting
  • University of South Florida Health South Tampa Center for Advanced Healthcare

    Tampa, Florida, United States

    Allison Wyman, MDEric S Chang, MDIsabel Prieto, MDKristie Greene, MDRenee Bassaly, DORyan Hidalgo, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Botulinum toxin type A →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
9 Oct 2019
Primary completion
1 Jan 2021
Completion
1 Jun 2021
Last update posted
5 Nov 2020
Registered enrollment
60
Registry id
NCT04305743
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.